Respiratory mucosal permeability in asthma.
The permeability of respiratory mucosa to technetium-labeled diethylenetriamine pentacetic acid (99mTc-DTPA) was measured in 10 clinically stable chronic asthmatics and the results were compared with those in 9 nonasthmatic control subjects. Nonspecific bronchial reactivity was measured using methacholine, and the PC20 was calculated. The intrapulmonary distribution and dose of the inhaled 99mTc-DTPA was determined by a gamma camera and the half-life of the aerosolized label in the lung was calculated. The accumulation of radioactivity in the blood was monitored and a permeability index was calculated at 10, 25, and 60 min after aerosolization. Despite marked differences in airway reactivity, no differences in either parameter of permeability could be detected between the asthmatics and the control group. It is concluded that clinically stable asthmatics do not demonstrate increase mucosal permeability to small solutes when compared with normal subjects.
D000328:Adult; D001249:Asthma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000378:metabolism*; D001980:Bronchi / Q000378:metabolism*; D001985:Bronchial Provocation Tests; D005260:Female; D005541:Forced Expiratory Volume; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000378:metabolism*; D004369:Pentetic Acid; D010539:Permeability; D011877:Radionuclide Imaging; D012137:Respiratory System / Q000000981:diagnostic imaging; D013667:Technetium; D016284:Technetium Tc 99m Pentetate
D013667:Technetium; D004369:Pentetic Acid; D016284:Technetium Tc 99m Pentetate